|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1973-8-7
|
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Age Factors,
http://linkedlifedata.com/resource/pubmed/keyword/Biology,
http://linkedlifedata.com/resource/pubmed/keyword/Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Endocrine System,
http://linkedlifedata.com/resource/pubmed/keyword/Estrogens--therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/Genitalia,
http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female,
http://linkedlifedata.com/resource/pubmed/keyword/Hormones,
http://linkedlifedata.com/resource/pubmed/keyword/Injectables,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, Combined,
http://linkedlifedata.com/resource/pubmed/keyword/Ovarian Effects,
http://linkedlifedata.com/resource/pubmed/keyword/Ovary,
http://linkedlifedata.com/resource/pubmed/keyword/Physiology,
http://linkedlifedata.com/resource/pubmed/keyword/Progestational Hormones,
http://linkedlifedata.com/resource/pubmed/keyword/Progesterone--therapeutic use,
http://linkedlifedata.com/resource/pubmed/keyword/Surgery,
http://linkedlifedata.com/resource/pubmed/keyword/Treatment,
http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
551-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:otherAbstract |
PIP: 286 patients between ages 16-48 with cystic adnexal masses were treated with estrogen and progesterone for 6 weeks. Persistence of the adnexal mass occurred in 81 patients and surgical exploration was done. All patients explored with an ovarian enlargement had an ovarian neoplasm causing the enlargement. There were 7 patients with normal sized ovaries but an associated paraovarian cyst or unilateral hydrosalpinx was found. No patient was subjected to surgical exploration with the finding of a physiologic cyst causing the adnexal mass. In this series, suppression of the pituitary gonadotropins for 6 weeks was long enough to cause all significant physiologic cysts to regress. It would seem that menstruating women with a cystic adnexal mass and a differential diagnosis that included a physiologic cyst should not be subjected to operations without a trial of pituitary suppressions. Also, the use of pituitary suppression with estrogen and progesterone removes indecision as to how long a physiologic cyst will remain before undergoing regression.
|
|
pubmed:meshHeading |
pubmed-meshheading:4709490-Adnexal Diseases,
pubmed-meshheading:4709490-Adolescent,
pubmed-meshheading:4709490-Adult,
pubmed-meshheading:4709490-Contraceptives, Oral,
pubmed-meshheading:4709490-Cysts,
pubmed-meshheading:4709490-Diagnosis, Differential,
pubmed-meshheading:4709490-Endometriosis,
pubmed-meshheading:4709490-Estrogens,
pubmed-meshheading:4709490-Female,
pubmed-meshheading:4709490-Humans,
pubmed-meshheading:4709490-Middle Aged,
pubmed-meshheading:4709490-Ovarian Cysts,
pubmed-meshheading:4709490-Ovarian Neoplasms,
pubmed-meshheading:4709490-Progestins,
pubmed-meshheading:4709490-Time Factors
|
|
pubmed:year |
1973
|
|
pubmed:articleTitle |
Preoperative hormonal therapy of cystic adnexal masses.
|
|
pubmed:publicationType |
Journal Article
|
